Figure 1. Region-level expression of AKT serine/threonine protein kinase isotypes and pathway components.
Open circles indicate females, closed circles indicate males. Analysis revealed increased expression of A) AKT1, B) AKT2, C) AKT3, D) FOXO1, E) PTEN, F) PDPK1, H) PHLPP2, and I) PPP2CA (*p<0.05). There was no significant change in gene expression of G) PHLPP1 in schizophrenia subjects compared to controls. Data are log-transformed and analyzed using either Student’s t-test or Welch’s t-test. Data expressed as mean +/− SEM, n=15–20/group. Abbreviations: AKT serine/threonine kinase 1 (AKT1), AKT serine/threonine kinase 2 (AKT2), AKT serine/threonine kinase 3 (AKT3), Forkhead box O1 (FOXO1), Phosphatase and tensin homolog (PTEN), 3-phosphoinositide dependent protein kinase 1 (PDPK1), PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), PH domain and leucine-rich repeat protein phosphatase 2 (PHLPP2), Protein phosphatase 2 catalytic subunit alpha (PPP2CA).
